# GUCA1A

## Overview
The GUCA1A gene encodes the protein guanylate cyclase activator 1A (GCAP1), which is a critical component in the phototransduction pathway of retinal photoreceptor cells. As a neuronal calcium sensor, GCAP1 modulates the activity of retinal guanylate cyclases in response to fluctuations in intracellular calcium levels, thereby playing a pivotal role in the recovery phase of visual transduction. This protein is characterized by its EF-hand motifs, which are essential for calcium binding and subsequent conformational changes that regulate its function. GCAP1's ability to form dimers is crucial for its interaction with guanylate cyclases, facilitating the precise control of cyclic guanosine monophosphate (cGMP) synthesis necessary for normal vision. Mutations in the GUCA1A gene can lead to hereditary retinal dystrophies, underscoring the clinical significance of this gene in maintaining visual health (Kitiratschky2009Mutations; Lim2014Structural; Lim2018Retinal).

## Structure
The GUCA1A gene encodes guanylate cyclase activating protein 1 (GCAP1), which plays a crucial role in phototransduction in the retina. GCAP1 is characterized by its primary structure, which includes a sequence of amino acids forming four EF-hand motifs. These motifs are essential for binding calcium ions, which induce conformational changes necessary for the protein's function (Kitiratschky2009Mutations; Lim2014Structural).

The secondary structure of GCAP1 includes alpha helices and beta sheets, which contribute to its overall stability and function (Lim2014Structural). The tertiary structure involves the folding of these elements into a three-dimensional shape, stabilized by the EF-hand motifs and a unique N-terminal myristoyl group. This myristoyl group is sequestered within the protein, bridging the N-terminal and C-terminal ends, and is crucial for transmitting calcium-induced conformational changes (Ames2021Structural; Lim2014Structural).

In terms of quaternary structure, GCAP1 forms dimers through hydrophobic intermolecular contacts at the dimer interface, involving residues such as H19, Y22, V77, and W94. These interactions are critical for its function in activating retinal guanylyl cyclase (Ames2021Structural; Lim2018Retinal). The dimerization is Ca2+-independent and involves conserved hydrophobic residues (Ames2022Structural).

## Function
The GUCA1A gene encodes guanylate cyclase-activating protein 1 (GCAP1), which plays a crucial role in the phototransduction process in retinal photoreceptor cells. GCAP1 functions as a neuronal calcium sensor, modulating the activity of retinal guanylate cyclase (GC) in response to changes in intracellular calcium (Ca2+) levels. In dark conditions, GCAP1 binds Ca2+ and inhibits GC activity, preventing the synthesis of cyclic guanosine monophosphate (cGMP). Upon exposure to light, the intracellular Ca2+ concentration decreases, leading to the replacement of Ca2+ with magnesium (Mg2+) in GCAP1. This conformational change activates GC, promoting cGMP synthesis and restoring the dark-adapted state of the photoreceptors (Dell’Orco2019Normal; Marino2018A).

GCAP1 is primarily active in the outer segments of rod and cone cells, where it helps maintain cGMP levels essential for normal vision. The protein's ability to sense and respond to Ca2+ fluctuations is vital for the recovery phase of visual transduction, ensuring that photoreceptors can quickly adapt to changes in light conditions (Buch2011Dominant). This regulation is critical for maintaining the balance of second messengers and ensuring proper visual function (Biasi2021A).

## Clinical Significance
Mutations in the GUCA1A gene, which encodes guanylate cyclase-activating protein 1 (GCAP1), are associated with several hereditary retinal dystrophies, including autosomal dominant cone dystrophy (adCD), cone-rod dystrophy (adCRD), and macular dystrophy. These conditions are characterized by progressive vision loss, impaired color vision, and photophobia (Kitiratschky2009Mutations; Payne1998A). Specific mutations, such as Y99C, Y99N, Y99S, L151F, and E111V, disrupt the calcium-binding ability of GCAP1, leading to persistent activation of retinal guanylate cyclase and elevated levels of cyclic guanosine monophosphate (cGMP), which can result in photoreceptor cell death (Buch2011Dominant; Marino2018A; Mizobuchi2019Characterization).

The prevalence of GUCA1A-associated inherited retinal diseases is relatively low, with a reported prevalence of 0.25% among Japanese patients with inherited retinal dystrophies (Mizobuchi2019Characterization). The clinical presentation of these conditions can vary significantly, with some patients exhibiting symptoms primarily affecting cone cells, while others experience both cone and rod dysfunction (Kamenarova2013NovelGUCA1AMutations). RNA interference (RNAi) therapies are being explored as potential treatments to silence the mutant GUCA1A gene and mitigate the effects of these mutations (Jiang2014RNA).

## Interactions
The GUCA1A gene encodes guanylate cyclase-activating protein 1 (GCAP1), which plays a crucial role in the regulation of retinal guanylate cyclases (RetGCs) in photoreceptor cells. GCAP1 interacts with RetGCs, modulating their activity in response to changes in intracellular calcium levels. This interaction is essential for the recovery phase of the photoresponse, as GCAP1 activates RetGCs at low calcium concentrations and inhibits them at higher calcium levels (Lim2018Retinal).

GCAP1 forms a functional dimer, which is important for its interaction with RetGCs. The dimerization of GCAP1 involves hydrophobic contacts at specific residues, such as H19, Y22, F73, and V77, and is thought to facilitate its binding to dimeric RetGC in a 2:2 complex. This dimerization may involve allosteric conformational changes that are crucial for its regulatory function (Lim2018Retinal).

Mutations in GUCA1A can lead to altered interactions with RetGCs, resulting in constitutive activation of the cyclase. For instance, the N104H variant of GCAP1 shows increased affinity for RetGC, leading to hyperactivation of the enzyme and potentially causing toxic accumulation of cGMP and calcium in photoreceptors (Biasi2021A).


## References


[1. (Ames2021Structural) James B. Ames. Structural insights into retinal guanylate cyclase activator proteins (gcaps). International Journal of Molecular Sciences, 22(16):8731, August 2021. URL: http://dx.doi.org/10.3390/ijms22168731, doi:10.3390/ijms22168731. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22168731)

[2. (Dell’Orco2019Normal) Daniele Dell’Orco and Giuditta Dal Cortivo. Normal gcaps partly compensate for altered cgmp signaling in retinal dystrophies associated with mutations in guca1a. Scientific Reports, December 2019. URL: http://dx.doi.org/10.1038/s41598-019-56606-5, doi:10.1038/s41598-019-56606-5. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-56606-5)

[3. (Marino2018A) Valerio Marino, Giuditta Dal Cortivo, Elisa Oppici, Paolo Enrico Maltese, Fabiana D’Esposito, Elena Manara, Lucia Ziccardi, Benedetto Falsini, Adriano Magli, Matteo Bertelli, and Daniele Dell’Orco. A novel p.(glu111val) missense mutation in guca1a associated with cone-rod dystrophy leads to impaired calcium sensing and perturbed second messenger homeostasis in photoreceptors. Human Molecular Genetics, September 2018. URL: http://dx.doi.org/10.1093/hmg/ddy311, doi:10.1093/hmg/ddy311. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddy311)

[4. (Biasi2021A) Amedeo Biasi, Valerio Marino, Giuditta Dal Cortivo, Paolo Enrico Maltese, Antonio Mattia Modarelli, Matteo Bertelli, Leonardo Colombo, and Daniele Dell’Orco. A novel guca1a variant associated with cone dystrophy alters cgmp signaling in photoreceptors by strongly interacting with and hyperactivating retinal guanylate cyclase. International Journal of Molecular Sciences, 22(19):10809, October 2021. URL: http://dx.doi.org/10.3390/ijms221910809, doi:10.3390/ijms221910809. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms221910809)

[5. (Kitiratschky2009Mutations) Veronique B.D. Kitiratschky, Petra Behnen, Ulrich Kellner, John R Heckenlively, Eberhart Zrenner, Herbert JÃ¤gle, Susanne Kohl, Bernd Wissinger, and Karl-Wilhelm Koch. Mutations in theguca1agene involved in hereditary cone dystrophies impair calcium-mediated regulation of guanylate cyclase. Human Mutation, 30(8):E782–E796, August 2009. URL: http://dx.doi.org/10.1002/humu.21055, doi:10.1002/humu.21055. This article has 67 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21055)

[6. (Lim2014Structural) Sunghyuk Lim, Alexander M. Dizhoor, and James B. Ames. Structural diversity of neuronal calcium sensor proteins and insights for activation of retinal guanylyl cyclase by gcap1. Frontiers in Molecular Neuroscience, March 2014. URL: http://dx.doi.org/10.3389/fnmol.2014.00019, doi:10.3389/fnmol.2014.00019. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2014.00019)

[7. (Kamenarova2013NovelGUCA1AMutations) Kunka Kamenarova, Marta Corton, Blanca García-Sandoval, Patricia Fernández-San Jose, Valentin Panchev, Almudena Ávila-Fernández, Maria Isabel López-Molina, Christina Chakarova, Carmen Ayuso, and Shomi S. Bhattacharya. Novelguca1amutations suggesting possible mechanisms of pathogenesis in cone, cone-rod, and macular dystrophy patients. BioMed Research International, 2013:1–15, 2013. URL: http://dx.doi.org/10.1155/2013/517570, doi:10.1155/2013/517570. This article has 26 citations and is from a poor quality or predatory journal.](https://doi.org/10.1155/2013/517570)

[8. (Ames2022Structural) James B. Ames. Structural basis of retinal membrane guanylate cyclase regulation by gcap1 and rd3. Frontiers in Molecular Neuroscience, September 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.988142, doi:10.3389/fnmol.2022.988142. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.988142)

[9. (Mizobuchi2019Characterization) Kei Mizobuchi, Takaaki Hayashi, Satoshi Katagiri, Kazutoshi Yoshitake, Kaoru Fujinami, Lizhu Yang, Kazuki Kuniyoshi, Kei Shinoda, Shigeki Machida, Mineo Kondo, Shinji Ueno, Hiroko Terasaki, Tomokazu Matsuura, Kazushige Tsunoda, Takeshi Iwata, and Tadashi Nakano. Characterization of guca1a-associated dominant cone/cone-rod dystrophy: low prevalence among japanese patients with inherited retinal dystrophies. Scientific Reports, November 2019. URL: http://dx.doi.org/10.1038/s41598-019-52660-1, doi:10.1038/s41598-019-52660-1. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-52660-1)

[10. (Buch2011Dominant) Prateek K. Buch, Marija Mihelec, Phillippa Cottrill, Susan E. Wilkie, Rachael A. Pearson, Yanai Duran, Emma L. West, Michel Michaelides, Robin R. Ali, and David M. Hunt. Dominant cone-rod dystrophy: a mouse model generated by gene targeting of the gcap1/guca1a gene. PLoS ONE, 6(3):e18089, March 2011. URL: http://dx.doi.org/10.1371/journal.pone.0018089, doi:10.1371/journal.pone.0018089. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0018089)

[11. (Payne1998A) A. Payne. A mutation in guanylate cyclase activator 1a (guca1a) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Human Molecular Genetics, 7(2):273–277, February 1998. URL: http://dx.doi.org/10.1093/hmg/7.2.273, doi:10.1093/hmg/7.2.273. This article has 171 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/7.2.273)

[12. (Lim2018Retinal) Sunghyuk Lim, Graham Roseman, Igor Peshenko, Grace Manchala, Diana Cudia, Alexander M. Dizhoor, Glenn Millhauser, and James B. Ames. Retinal guanylyl cyclase activating protein 1 forms a functional dimer. PLOS ONE, 13(3):e0193947, March 2018. URL: http://dx.doi.org/10.1371/journal.pone.0193947, doi:10.1371/journal.pone.0193947. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0193947)

[13. (Jiang2014RNA) Li Jiang, Jeanne M. Frederick, and Wolfgang Baehr. Rna interference gene therapy in dominant retinitis pigmentosa and cone-rod dystrophy mouse models caused by gcap1 mutations. Frontiers in Molecular Neuroscience, April 2014. URL: http://dx.doi.org/10.3389/fnmol.2014.00025, doi:10.3389/fnmol.2014.00025. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2014.00025)